121 results
Page 2 of 7
8-K
EX-99.1
sv5bx14p7
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
8-K
EX-99.1
yajn z6iggobgy7r
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
8-K
EX-99.1
ar8u 8urp
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
EX-99.1
3qsfxl 26eivu
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
EX-99.1
p1gc61w3cetl jecv8
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am
8-K
EX-99.1
nr79l57m bbd
25 Apr 22
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
7:12am
8-K
EX-99.1
n0mw620nl6ti djx
21 Apr 22
Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
8:08am
8-K
EX-99.1
dj4czq1ju18n
1 Mar 22
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update
7:49am
8-K
EX-99.1
3lh4jwgomh7liy zpe
7 Jan 22
Other Events
4:12pm
8-K
EX-99.2
st595g7nl17nyzhx
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
424B5
xwkabd96irj44lxim
5 Jan 22
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.2
zmqzinsw3zk33rzvav
4 Jan 22
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am